Trulieve Cannabis (TCNNF) Retained Earnings (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Retained Earnings of -$909.7 million in Q1 2026, little changed quarter-over-quarter from -$912.1 million in Q4 2025, and down 9.79% on a YoY basis from -$1.0 billion in Q1 2025.
Trulieve Cannabis (TCNNF) Retained Earnings (2020 - 2026) Analysis & Trends
Trulieve Cannabis' Retained Earnings history runs 7 years deep, the most recent figure standing at -$909.7 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 9.79% year-over-year to -$909.7 million; the TTM figure through Mar 2026 stood at -$909.7 million (down 9.79% YoY), while the FY2025 annual figure was -$912.1 million, down 14.63% from the prior year.
- Retained Earnings was -$909.7 million for Q1 2026 at Trulieve Cannabis, roughly flat from -$912.1 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $105.7 million in Q1 2022 to a low of -$912.1 million in Q4 2025.
- Historically, Retained Earnings has averaged -$541.0 million across 5 years, with a median of -$663.7 million in 2024.
- The sharpest annual moves came in 2023 and 2026: Retained Earnings plunged 1840.02% in 2023, then dropped 9.79% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$113.8 million in 2022, then tumbled by 462.74% to -$640.6 million in 2023, then decreased by 24.21% to -$795.7 million in 2024, then declined by 14.63% to -$912.1 million in 2025, then increased by 0.26% to -$909.7 million in 2026.
- The last three Retained Earnings figures came in at -$909.7 million (Q1 2026), -$912.1 million (Q4 2025), and -$869.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | -909.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -909.72 Mn |
| Dec 31, 2025 | -912.13 Mn |
| Sep 30, 2025 | -869.23 Mn |
| Jun 30, 2025 | -842.39 Mn |
| Mar 31, 2025 | -828.61 Mn |
| Dec 31, 2024 | -795.74 Mn |
| Sep 30, 2024 | -735.96 Mn |
| Jun 30, 2024 | -675.75 Mn |
| Mar 31, 2024 | -663.72 Mn |
| Dec 31, 2023 | -640.64 Mn |
| Sep 30, 2023 | -607.21 Mn |
| Jun 30, 2023 | -581.82 Mn |
| Mar 31, 2023 | -177.97 Mn |
| Dec 31, 2022 | -113.84 Mn |
| Sep 30, 2022 | -31.30 Mn |
| Jun 30, 2022 | 83.26 Mn |
| Mar 31, 2022 | 105.75 Mn |
| Dec 31, 2021 | 137.72 Mn |
| Sep 30, 2021 | 209.26 Mn |
| Jun 30, 2021 | 190.65 Mn |